{"organizations": [], "uuid": "eea6566247412fb22e927a38b41f3fa320b8d056", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180125.html", "section_title": "Archive News &amp; Video for Thursday, 25 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/drreddys-results/indias-dr-reddys-q3-profit-tumbles-hit-by-u-s-pricing-pressure-idUSL4N1PK2FY", "country": "US", "domain_rank": 408, "title": "India's Dr. Reddy's Q3 profit tumbles, hit by U.S. pricing pressure", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-25T14:34:00.000+02:00", "replies_count": 0, "uuid": "eea6566247412fb22e927a38b41f3fa320b8d056"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/drreddys-results/indias-dr-reddys-q3-profit-tumbles-hit-by-u-s-pricing-pressure-idUSL4N1PK2FY", "ord_in_thread": 0, "title": "India's Dr. Reddy's Q3 profit tumbles, hit by U.S. pricing pressure", "locations": [], "entities": {"persons": [{"name": "reddy", "sentiment": "negative"}, {"name": "jessica kuruthukulangara", "sentiment": "none"}, {"name": "edwina gibbs", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "india", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}, {"name": "united states", "sentiment": "none"}], "organizations": [{"name": "laboratories ltd", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 25 (Reuters) - Indian generic drugmaker Dr. Reddyâ€™s Laboratories Ltd posted a 38.5 percent slump in quarterly net profit as sales declined due to pricing pressure in the United States, its biggest market.\nNet profit was 3.03 billion rupees ($47.7 million) in the third quarter ended Dec. 31, compared with 4.92 billion rupees a year earlier, the company said. bit.ly/2BubKli\nThat compares with an average estimate of 3.4 billion rupees from 13 analysts polled by Thomson Reuters I/B/E/S.\n$1 = 63.4900 Indian rupees Reporting by Jessica Kuruthukulangara in Bengaluru; Editing by Edwina Gibbs\n ", "external_links": ["http://bit.ly/2BubKli", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-25T14:34:00.000+02:00", "crawled": "2018-01-26T21:39:18.000+02:00", "highlightTitle": ""}